DrFirst Reduces Physician Burden Through Well-Designed Medication Management

Why It Matters

Reducing prescription friction accelerates care delivery, cuts costs, and strengthens provider‑patient trust, giving health systems a competitive advantage.

Key Takeaways

• DrFirst offers end‑to‑end medication management across EHRs, pharmacies, PBMs.
• Prescription orchestration reduces downstream rework by embedding rules upstream.
• Actionable clinical decision support must earn provider trust through relevance.
• AI/LLM integration enables on‑the‑fly dosing guidance within workflow.
• Prior‑authorization strategy: avoid, accelerate, automate to streamline specialty meds.

Summary

The interview with Dr. Colin Bannis and Drew Huninger of DrFirst focuses on how the company is tackling physician burden by providing a comprehensive medication management platform that spans prescribing, pharmacy, and patient interfaces.

They explain that modern prescribing has become a “game with unknown rules,” requiring providers to consider coverage, cost, and regulatory constraints. DrFirst’s prescription orchestration embeds these rules into the workflow, delivering actionable clinical decision support that reduces downstream rework and “ping‑pong” errors.

Notable quotes: “Providers have been asked to play a game that they haven’t been told the rules to,” and “Trust is earned once and lost forever.” The team highlights AI/LLM tools that answer dosing questions in‑app and a three‑step prior‑authorization mantra—avoid, accelerate, automate—to cut manual effort.

The implications are clear: by integrating decision support and AI directly into EHR workflows, DrFirst aims to improve prescribing efficiency, lower administrative costs, and enhance patient access to specialty therapies, setting a benchmark for health‑IT vendors.

Original Description

Prescribing medication has become unfathomably complex these days, with rules interposed between the patient and physician by pharmacies, payers, and pharmacy benefit managers (PBMs). Drew Hunsinger, Executive VP, Corporate Strategy at DrFirst, points out that a single medication may have multiple indications (conditions for which it can be prescribed) and rules vary by indication. Colin Banas, MD, Chief Medical Officer, says that 90% of new medications are considered specialty medications with associated complex rules.

Learn more about DrFirst: https://drfirst.com/

Healthcare IT Community: https://www.healthcareittoday.com/